{
  "ptid_time": "131_S_0123_2007-02-15",
  "img_path": "/data/qiuhui/data/adni/images/131_S_0123/2007-02-15/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 33,136 mm³, 14.0% below the reference mean. With a Z-score of -0.33 (36.9th percentile), this represents normal volume ; hippocampal volume measures 6,176 mm³, 18.3% below the reference mean. With a Z-score of -1.78 (3.7th percentile), this represents moderate atrophy; whole brain volume measures 930,154 mm³, 13.8% below the reference mean. With a Z-score of -1.79 (3.6th percentile), this represents moderate atrophy; entorhinal cortex volume measures 2,294 mm³, 44.1% below the reference mean. With a Z-score of -2.99 (0.1th percentile), this represents significant atrophy; fusiform gyrus volume measures 14,368 mm³, 23.7% below the reference mean. With a Z-score of -2.02 (2.2th percentile), this represents significant atrophy; middle temporal gyrus volume measures 15,504 mm³, 27.3% below the reference mean. With a Z-score of -2.46 (0.7th percentile), this represents significant atrophy. ",
  "text_data": "Age is 74.3 years. Gender is Male. Education: 20 years. MMSE: 30.0. Logical Memory: 19.0. APOEε4 alleles: 0.0. Biomarker levels: Amyloid beta: 1553.00 pg/mL (mild elevated); Total tau: 293.80 pg/mL (normal ); Phosphorylated tau: 26.48 pg/mL (normal ). ",
  "true_diagnosis": "Diagnosis: CN.",
  "gpt_diagnosis": "**Reasoning:** The brain imaging shows significant atrophy in key Alzheimer's-related regions (hippocampus, entorhinal cortex, fusiform gyrus, middle temporal gyrus) despite normal cognitive scores (MMSE 30). Mildly elevated Aβ with normal tau suggests early amyloid pathology, but the structural changes are more severe than expected for preclinical stages.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)** (likely amyloid-positive, non-amnestic subtype given preserved MMSE but significant temporal lobe atrophy).  \n\n**Confidence:** **Medium** (high confidence in neurodegeneration, but clinical-cognitive discordance and normal tau complicate staging; progression to dementia is likely but not yet diagnosable).  \n\n*Note:* Close monitoring is advised—longitudinal cognitive decline or tau elevation would upgrade this to \"Dementia due to Alzheimer’s.\" APOE4-negative status may suggest slower progression.",
  "timestamp": "2025-07-26T14:59:08.411215"
}